Acute pain. Other acute postprocedural pain
Conditions
Interventions
Intervention 1: Intervention group: The first group made use of EMLA cream, made by Astrazeneca,Eczacibasi Ltd, Turkey. Cream surface is covered by a piece of paper and a 2 cc syringe was used to appl
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age over 18 years History of at least 3 months of hemodialysis No addiction or dependence on painkillers No pain before cannulation Do not use the sedative at the last 24 hours No wounds in the fistula area No history of skin allergies, or dermatitis Not treated with sulfonamides, nitrates and phenobarbital Not having a pacemaker No history of Alzheimer's disease, dementia, peripheral vascular disease, diabetic neuropathy, liver disease Lack of respiratory problems, brain problems, glaucoma, increased intracranial pressure and recent eye surgery
Exclusion criteria
Exclusion criteria: Patients who are unable to perform the Valsalva maneuver by holding the mercury column above 20 mm Hg for 20 seconds Unsuccessful cannulation in the first step and repeated insertion of the needle into the skin Patients with known heart attack or those with hemodynamic problems or dangerous arrhythmias
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of the pain. Timepoint: The first stage without intervention - the second stage after the intervention. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHassan Babamohamadi
Semnan University of Medical Sciences
Outcome results
None listed